United States · Bill · HR
H.R. 2315 (113th)
Preserving Access to Orphan Drugs Act of 2013
Introduced
11 June 2013
Last action
25 July 2013 · Introduced
Status
Rereferred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsors
Rep. Gerlach, Jim [R-PA-6], Rep. Neal, Richard E. [D-MA-1], Rep. Burgess, Michael C. [R-TX-26], Rep. McKinley, David B. [R-WV-1], Rep. Schwartz, Allyson Y. [D-PA-13], Rep. Carson, André [D-IN-7], Rep. Thompson, Glenn [R-PA-15], Rep. Kinzinger, Adam [R-IL-16], Rep. Paulsen, Erik [R-MN-3], Rep. Polis, Jared [D-CO-2], Rep. Griffin, Tim [R-AR-2], Rep. Perlmutter, Ed [D-CO-7], Rep. Owens, William L. [D-NY-23], Rep. Murphy, Patrick [D-FL-18], Rep. Nunes, Devin [R-CA-22], Rep. Engel, Eliot L. [D-NY-16], Rep. Rangel, Charles B. [D-NY-15], Rep. Kelly, Mike [R-PA-16], Rep. Jenkins, Lynn [R-KS-2], Rep. Meehan, Patrick [R-PA-7], Rep. Guthrie, Brett [R-KY-2], Rep. Lance, Leonard [R-NJ-7], Rep. McMorris Rodgers, Cathy [R-WA-5], Rep. Marchant, Kenny [R-TX-24], Sen. Young, Todd [R-IN], Rep. Pompeo, Mike [R-KS-4], Rep. McCaul, Michael T. [R-TX-10], Rep. Wolf, Frank R. [R-VA-10], James Renacci, Rep. Kind, Ron [D-WI-3], Rep. Latham, Tom [R-IA-3], Rep. Dent, Charles W. [R-PA-15], Rep. Rokita, Todd [R-IN-4], Rep. Frankel, Lois [D-FL-22], Rep. Brooks, Susan W. [R-IN-5], Rep. Boustany, Charles W., Jr. [R-LA-3], Rep. Nolan, Richard M. [D-MN-8], Rep. Schrader, Kurt [D-OR-5], Rep. Cohen, Steve [D-TN-9], Rep. Loebsack, David [D-IA-2], Rep. Tiberi, Patrick J. [R-OH-12], Rep. Johnson, Eddie Bernice [D-TX-30], Rep. King, Peter T. [R-NY-2], Rep. Gibson, Christopher P. [R-NY-19], Rep. Johnson, Bill [R-OH-6], Rep. Black, Diane [R-TN-6], Rep. Murphy, Tim [R-PA-18], Rep. Rothfus, Keith J. [R-PA-12]
Subjects
Healthcare
Source updated
5 December 2025
Summary
Preserving Access to Orphan Drugs Act of 2013 - Amends the Patient Protection and Affordable Care Act (PPACA) to exclude any drug or biological product which is approved or licensed by the Food and Drug Administration (FDA) for marketing solely for one or more rare diseases or conditions (orphan drug) from the annual fee on manufacturers or importers with branded prescription drug sales exceeding $5 million. Makes this Act effective as if included in PPACA.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
11 June 2013
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
11 June 2013
Introduced
Introduced in House
Source: IntroReferral
11 June 2013
Introduced
Introduced in House
Source: IntroReferral
14 June 2013
Referred
Referred to the Subcommittee on Health.
Source: Committee
25 July 2013
Introduced
Rereferred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Introduced in House · 11 June 2013 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 11 June 2013
Introduced in House (PDF)
Introduced in House · EN · 11 June 2013
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 11 June 2013
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Gerlach, Jim [R-PA-6] · R · Sponsor
- Rep. Neal, Richard E. [D-MA-1] · D · Sponsor
- Rep. Burgess, Michael C. [R-TX-26] · R · Cosponsor
- Rep. McKinley, David B. [R-WV-1] · R · Cosponsor
- Rep. Schwartz, Allyson Y. [D-PA-13] · D · Cosponsor
- Rep. Carson, André [D-IN-7] · D · Cosponsor
- Rep. Thompson, Glenn [R-PA-15] · R · Cosponsor
- Rep. Kinzinger, Adam [R-IL-16] · R · Cosponsor
- Rep. Paulsen, Erik [R-MN-3] · R · Cosponsor
- Rep. Polis, Jared [D-CO-2] · D · Cosponsor
- Rep. Griffin, Tim [R-AR-2] · R · Cosponsor
- Rep. Perlmutter, Ed [D-CO-7] · D · Cosponsor
- Rep. Owens, William L. [D-NY-23] · D · Cosponsor
- Rep. Murphy, Patrick [D-FL-18] · D · Cosponsor
- Rep. Nunes, Devin [R-CA-22] · R · Cosponsor
- Rep. Engel, Eliot L. [D-NY-16] · D · Cosponsor
- Rep. Rangel, Charles B. [D-NY-15] · D · Cosponsor
- Rep. Kelly, Mike [R-PA-16] · R · Cosponsor
- Rep. Jenkins, Lynn [R-KS-2] · R · Cosponsor
- Rep. Meehan, Patrick [R-PA-7] · R · Cosponsor
- Rep. Guthrie, Brett [R-KY-2] · R · Cosponsor
- Rep. Lance, Leonard [R-NJ-7] · R · Cosponsor
- Rep. McMorris Rodgers, Cathy [R-WA-5] · R · Cosponsor
- Rep. Marchant, Kenny [R-TX-24] · R · Cosponsor
- Sen. Young, Todd [R-IN] · R · Cosponsor
- Rep. Pompeo, Mike [R-KS-4] · R · Cosponsor
- Rep. McCaul, Michael T. [R-TX-10] · R · Cosponsor
- Rep. Wolf, Frank R. [R-VA-10] · R · Cosponsor
- James Renacci · R · Cosponsor
- Rep. Kind, Ron [D-WI-3] · D · Cosponsor
- Rep. Latham, Tom [R-IA-3] · R · Cosponsor
- Rep. Dent, Charles W. [R-PA-15] · R · Cosponsor
- Rep. Rokita, Todd [R-IN-4] · R · Cosponsor
- Rep. Frankel, Lois [D-FL-22] · D · Cosponsor
- Rep. Brooks, Susan W. [R-IN-5] · R · Cosponsor
- Rep. Boustany, Charles W., Jr. [R-LA-3] · R · Cosponsor
- Rep. Nolan, Richard M. [D-MN-8] · D · Cosponsor
- Rep. Schrader, Kurt [D-OR-5] · D · Cosponsor
- Rep. Cohen, Steve [D-TN-9] · D · Cosponsor
- Rep. Loebsack, David [D-IA-2] · D · Cosponsor
- Rep. Tiberi, Patrick J. [R-OH-12] · R · Cosponsor
- Rep. Johnson, Eddie Bernice [D-TX-30] · D · Cosponsor
- Rep. King, Peter T. [R-NY-2] · R · Cosponsor
- Rep. Gibson, Christopher P. [R-NY-19] · R · Cosponsor
- Rep. Johnson, Bill [R-OH-6] · R · Cosponsor
- Rep. Black, Diane [R-TN-6] · R · Cosponsor
- Rep. Murphy, Tim [R-PA-18] · R · Cosponsor
- Rep. Rothfus, Keith J. [R-PA-12] · R · Cosponsor
Showing 48 of 56 sponsors and actors.
Related records
- related to ← Preserving Access to Orphan Drugs Act of 2013
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/113th-congress/house-bill/2315
- Open data entity: https://api.congress.gov/v3/bill/113/hr/2315
- us · 113-hr-2315 · source updated 5 December 2025